604 studies found for:    Open Studies | "Bone Marrow Diseases"
Show Display Options
Rank Status Study
21 Recruiting Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
Condition: Tumor With Bone Metastasis
Interventions: Other: quality of life questionaries;   Drug: intravenous or oral bone antiresorptive treatments
22 Recruiting Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Conditions: Prostate Cancer;   Bone Metastases
Intervention: Drug: [68Ga]P15-041
23 Recruiting A Study to Collect Data About Analgesia in Patients With Bone Metastasis
Condition: Bone Metastasis
Interventions: Other: Questionnaires completion;   Other: Clinical Pain Assessments
24 Recruiting The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones
Condition: Bone Metastasis
Interventions: Procedure: Stabilisation of (impending) pathological fracture;   Radiation: Radiotherapy of bone metastasis
25 Recruiting Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy
Condition: Bone Metastasis
Interventions: Drug: fentanyl transmucosal;   Drug: Placebo
26 Recruiting Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS
Condition: Bone Metastases
Intervention: Radiation: Radiotherapy
27 Recruiting Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Condition: Bone Metastases
Intervention: Other: blood sampling, the SF-36 questionnaire
28 Recruiting Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases
Condition: Bone Metastases
Interventions: Radiation: Conventional Radiotherapy;   Radiation: Biological image-guided radiotherapy with conventional dose.;   Radiation: Biological image-guided SBRT with dose-escalation.
29 Not yet recruiting Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders
Condition: Myeloproliferative Neoplasms
Intervention:
30 Recruiting Italian Network MDS Registry
Condition: Myelodysplastic-Myeloproliferative Diseases
Intervention:
31 Recruiting PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis
Conditions: Primary Myelofibrosis;   Myeloproliferative Disorders
Interventions: Procedure: Allogeneic hematopoietic stem cell transplantation;   Drug: Busulfan;   Drug: Fludarabine monophosphate;   Drug: Cyclophosphamide;   Drug: Ruxolitinib
32 Not yet recruiting Exploring the Mechanisms of Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine Kinase Inhibitors in 3d Model Niche Endosteal
Condition: Myeloproliferative Disorders
Intervention:
33 Recruiting Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)
Conditions: Leukemia;   Lymphoma;   Myeloma;   Myeloproliferative Diseases
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Clofarabine;   Drug: Rabbit ATG;   Radiation: Total Body Irradiation (TBI);   Procedure: Cord Blood Infusions;   Drug: Rituximab;   Drug: Cyclophosphamide;   Procedure: Natural Killer Cell Infusion;   Drug: Melphalan;   Drug: Mesna
34 Recruiting Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
Condition: Myeloproliferative Diseases
Interventions: Drug: Ruxolitinib;   Drug: Pracinostat;   Behavioral: Questionnaire
35 Recruiting Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
Condition: Myeloproliferative Neoplasms
Interventions: Drug: Ruxolitinib;   Drug: Decitabine
36 Recruiting Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Condition: MDS
Interventions: Procedure: Allogeneic Hematopoietic Cell Transplant;   Procedure: Hypomethylating Therapy / Best Supportive Care
37 Recruiting Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms
Condition: Chronic Myeloproliferative Neoplasms
Intervention: Drug: Givinostat
38 Recruiting The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
Conditions: Metastatic Solid Tumor;   Lymphoma;   Myeloproliferative Neoplasms (MPN)
Intervention: Drug: PU-H71
39 Not yet recruiting A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Eltrombopag;   Drug: hATG;   Drug: CsA
40 Not yet recruiting Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: eltrombopag;   Drug: Cyclosporine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.